● The company usually posts poor financials for mid or long term investments.
● The company has solid fundamentals for a short-term investment strategy.
Strengths
● The prospective high growth for the next fiscal years is among the main assets of the company
● Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
● For the past twelve months, EPS forecast has been revised upwards.
● The stock is in a well-established, long-term rising trend above the technical support level at 329.94 USD
Weaknesses
● Stock prices approach a strong long-term resistance in weekly data at USD 552.33.
● Technically, the stock approaches a strong medium-term resistance at USD 537.92.
● Low profitability weakens the company.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
● With an enterprise value anticipated at 4.08 times the sales for the current fiscal year, the company turns out to be overvalued.
● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
● For the past year, analysts have significantly revised downwards their profit estimates.
● The three month average target prices set by analysts do not offer high potential in comparison with the current prices.